Evidence map›Paper›PMID 30791369›Full record

ReviewInternational journal of molecular sciences2019

New Insights into the Role of Epithelial⁻Mesenchymal Transition during Aging.

Francisco Santos, Cristiana Moreira, Sandrina Nóbrega-Pereira, Bruno Bernardes de Jesus

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. International journal of molecular sciences · 2026
    Article
  3. Science advances · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Advances in the study of the relationship betweenFrontiers in cell and developmental biology · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Revisiting Epithelial Carcinogenesis.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Francisco SantosDepartment of Medical Sciences and Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal. franciscojfsantos@ua.pt.
Cristiana MoreiraDepartment of Medical Sciences and Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal. cristi.moreira@ua.pt.
Sandrina Nóbrega-PereiraDepartment of Medical Sciences and Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal. sandrina.pereira@medicina.ulisboa.pt.
Bruno Bernardes de JesusDepartment of Medical Sciences and Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal. brunob.jesus@ua.pt.ORCID 0000-0002-6407-3466
University of Aveiro · PTUniversity of Lisbon · PT

Funding

Fundação para a Ciência e a Tecnologia LISBOA-01-0145-FEDER-028534Fundação para a Ciência e a Tecnologia PTDC/BIM-MED/0032/2014
6 · The paper itself

Abstract

Epithelial⁻mesenchymal transition (EMT) is a cellular process by which differentiated epithelial cells undergo a phenotypic conversion to a mesenchymal nature. The EMT has been increasingly recognized as an essential process for tissue fibrogenesis during disease and normal aging. Higher levels of EMT proteins in aged tissues support the involvement of EMT as a possible cause and/or consequence of the aging process. Here, we will highlight the existing understanding of EMT supporting the phenotypical alterations that occur during normal aging or pathogenesis, covering the impact of EMT deregulation in tissue homeostasis and stem cell function.

Indexed as

Epithelial-Mesenchymal TransitionAgingAnimalsCell DifferentiationCellular ReprogrammingCellular SenescenceHumansStem Cellsagingcellular reprogrammingEMTepithelial–mesenchymal transitionfibrosis

Identifiers

PMID30791369
PMCPMC6412502
OpenAlexW2913817601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.